BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• BioForest

  BIOTRONIK Initiates Study Validating Safe And Efficient In-Office Insertion Of BioMonitor 2 Cardiac Monitor

  December 5, 2016

   · 

  3 min read
• Drug Development

  Global Blood Therapeutics Announces New Long-Term Clinical Data From Ongoing Phase I/II Trial Of GBT440 In Sickle Cell Disease At American Society of Hematology

  December 5, 2016

   · 

  9 min read
• Drug Development

  Juno Shows Off Positive Early Data in Leukemia Patients

  December 5, 2016

   · 

  7 min read
• Drug Development

  Daiichi Sankyo Presents Phase 1 Data For MDM2 Inhibitor DS-3032 In Acute Myeloid Leukemia And Myelodysplastic Syndrome At The 58th Annual Meeting Of The American Society of Hematology

  December 5, 2016

   · 

  7 min read
• Nordic Nanovector: Single-Dose Betalutin Shows Promising Efficacy, Improved Duration Of Response And Favourable Safety In Relapsed NHL Patients

  December 5, 2016

   · 

  3 min read
• Drug Development

  Janssen R&D Release: Data At American Society of Hematology 2016 Show Strong, Lasting Efficacy Of IMBRUVICA (Ibrutinib) Through Five Years Of Treatment For Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

  December 5, 2016

   · 

  12 min read
• FDA

  Boehringer Ingelheim Release: FDA Approves Jardiance To Reduce Cardiovascular Death In Adults With Type 2 Diabetes

  December 5, 2016

   · 

  3 min read
• Drug Development

  Immune Design Corporation Provides Update From Two Discovery Platforms: DC-Tropic Zvex Delivering Multiple Tumor Antigens (Conserved And Neo-Antigens) And G100 For Intratumoral Immunotherapy

  December 5, 2016

   · 

  7 min read
• Drug Development

  Celldex Presents Data On CDX-1140, A Novel CD40 Agonist Antibody For Hematologic And Solid Malignancies, At The American Society of Hematology Annual Meeting

  December 5, 2016

   · 

  6 min read
• Drug Development

  EyeGate Pharma Reports Positive Data From Third Stage Of Phase Ib/IIa Clinical Trial Of EGP-437 In Cataract Surgery Patients

  December 5, 2016

   · 

  5 min read